JPWO2023032940A5 - - Google Patents
Info
- Publication number
- JPWO2023032940A5 JPWO2023032940A5 JP2023545576A JP2023545576A JPWO2023032940A5 JP WO2023032940 A5 JPWO2023032940 A5 JP WO2023032940A5 JP 2023545576 A JP2023545576 A JP 2023545576A JP 2023545576 A JP2023545576 A JP 2023545576A JP WO2023032940 A5 JPWO2023032940 A5 JP WO2023032940A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- pharmaceutically acceptable
- acceptable salt
- alkyl
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021142742 | 2021-09-01 | ||
| PCT/JP2022/032483 WO2023032940A1 (ja) | 2021-09-01 | 2022-08-30 | 含窒素三環性化合物及びその医薬用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023032940A1 JPWO2023032940A1 (https=) | 2023-03-09 |
| JPWO2023032940A5 true JPWO2023032940A5 (https=) | 2025-09-02 |
Family
ID=85411243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023545576A Pending JPWO2023032940A1 (https=) | 2021-09-01 | 2022-08-30 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240417406A1 (https=) |
| EP (1) | EP4438040A4 (https=) |
| JP (1) | JPWO2023032940A1 (https=) |
| KR (1) | KR20240055793A (https=) |
| CN (1) | CN117897382A (https=) |
| AR (1) | AR126913A1 (https=) |
| AU (1) | AU2022337617A1 (https=) |
| CA (1) | CA3228249A1 (https=) |
| CL (1) | CL2024000633A1 (https=) |
| CO (1) | CO2024003629A2 (https=) |
| IL (1) | IL311162A (https=) |
| MX (1) | MX2024002705A (https=) |
| PE (1) | PE20240920A1 (https=) |
| TW (1) | TW202319051A (https=) |
| WO (1) | WO2023032940A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR114237A1 (es) * | 2018-02-01 | 2020-08-05 | Japan Tobacco Inc | Compuesto de amida heterocíclica que contiene nitrógeno y su uso farmacéutico |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2381581A1 (en) * | 1999-09-04 | 2001-03-15 | Astrazeneca Ab | Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| AR074797A1 (es) * | 2008-10-10 | 2011-02-16 | Japan Tobacco Inc | Compuesto de fluoreno , composiciones farmaceuticas , inhibidores de pdhk y pdhk2 , metodos de tratamiento , usos de los mismos y kit comercial |
| BR112015022077A2 (pt) * | 2013-03-15 | 2017-07-18 | Japan Tobacco Inc | composto de pirazol-amida e usos medicinais do mesmo |
| EP3328857B1 (en) * | 2015-07-31 | 2019-08-14 | Merck Patent GmbH | Bicyclic heterocyclic derivatives |
| AR114237A1 (es) | 2018-02-01 | 2020-08-05 | Japan Tobacco Inc | Compuesto de amida heterocíclica que contiene nitrógeno y su uso farmacéutico |
| CN112638377A (zh) * | 2018-09-11 | 2021-04-09 | 日本烟草产业株式会社 | 含有吡唑酰胺化合物的慢性肾脏病的治疗或预防剂 |
| MX2021010692A (es) * | 2019-03-04 | 2021-10-01 | Japan Tobacco Inc | Dispersion solida amorfa de compuesto de pirazol-amida. |
| PL4116301T3 (pl) * | 2020-03-04 | 2026-02-16 | Japan Tobacco Inc. | Skondensowany związek tricykliczny i jego zastosowanie medyczne |
-
2022
- 2022-08-30 AU AU2022337617A patent/AU2022337617A1/en active Pending
- 2022-08-30 EP EP22864522.2A patent/EP4438040A4/en active Pending
- 2022-08-30 CN CN202280059611.6A patent/CN117897382A/zh active Pending
- 2022-08-30 JP JP2023545576A patent/JPWO2023032940A1/ja active Pending
- 2022-08-30 AR ARP220102332A patent/AR126913A1/es unknown
- 2022-08-30 KR KR1020247010319A patent/KR20240055793A/ko active Pending
- 2022-08-30 US US18/578,932 patent/US20240417406A1/en active Pending
- 2022-08-30 CA CA3228249A patent/CA3228249A1/en active Pending
- 2022-08-30 PE PE2024000368A patent/PE20240920A1/es unknown
- 2022-08-30 WO PCT/JP2022/032483 patent/WO2023032940A1/ja not_active Ceased
- 2022-08-30 TW TW111132707A patent/TW202319051A/zh unknown
- 2022-08-30 IL IL311162A patent/IL311162A/en unknown
- 2022-08-30 MX MX2024002705A patent/MX2024002705A/es unknown
-
2024
- 2024-02-29 CL CL2024000633A patent/CL2024000633A1/es unknown
- 2024-03-22 CO CONC2024/0003629A patent/CO2024003629A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019131544A5 (https=) | ||
| JP2015524443A5 (https=) | ||
| JP2025090726A5 (https=) | ||
| JP2023529354A5 (https=) | ||
| JP2019531320A5 (https=) | ||
| JP2022007994A5 (https=) | ||
| JP2017504640A5 (https=) | ||
| JPWO2023032940A5 (https=) | ||
| CA2798610A1 (en) | Bicyclic heteroaryl compounds as gpr119 modulators | |
| RU2016101964A (ru) | СТИМУЛЯТОРЫ sGC | |
| JP2014521700A5 (https=) | ||
| WO2005123680B1 (en) | Six-membered heterocycles useful as serine protease inhibitors | |
| RU2005118982A (ru) | Производные замещенного дигидропираноиндол-3, 4-диона как ингибиторы ингибитора-1 активатора плазминогена (pai) | |
| ZA202209620B (en) | Fused tricyclic compound and medicinal use thereof | |
| JP2012526769A5 (https=) | ||
| IL320810A (en) | Glucagon-like peptide 1 receptor agonists | |
| RU2007106869A (ru) | Тиазол-нафтиловые кислоты как ингибиторы ингибитора активации плазминогена-1 | |
| RU2007106868A (ru) | Оксазол-нафтиловые кислоты и их применение в качестве модуляторов ингибитора активатора плазминогена-1 (pai) для лечения тромбоза и сердечно-сосудистых заболеваний | |
| JP2018522024A5 (https=) | ||
| JP2019507167A5 (https=) | ||
| RU2024108335A (ru) | Азотсодержащее трициклическое соединение и его фармацевтическое применение | |
| CL2024000633A1 (es) | Compuesto tricíclico que contiene nitrógeno y su uso farmacéutico. | |
| RU2004136583A (ru) | Применение валсартана или его метаболита для ингибирования агрегации тромбоцитов | |
| JP2009504762A5 (https=) | ||
| JP2013500298A (ja) | 高齢かつ腎障害の非ｓｔ上昇型心筋梗塞患者の処置のためのオタミキサバン |